Compare CCC & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCC | ICUI |
|---|---|---|
| Founded | 1980 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.0B |
| IPO Year | 2020 | 1995 |
| Metric | CCC | ICUI |
|---|---|---|
| Price | $7.66 | $173.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $7.75 | ★ $194.25 |
| AVG Volume (30 Days) | ★ 17.8M | 229.0K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | 0.11 | ★ 3.02 |
| Revenue | $1,057,001,000.00 | ★ $2,231,262,000.00 |
| Revenue This Year | $10.10 | N/A |
| Revenue Next Year | $8.75 | $4.35 |
| P/E Ratio | $70.05 | ★ $58.22 |
| Revenue Growth | ★ 11.88 | N/A |
| 52 Week Low | $4.08 | $113.37 |
| 52 Week High | $8.68 | $192.85 |
| Indicator | CCC | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 52.41 |
| Support Level | $5.72 | $153.75 |
| Resistance Level | $7.68 | $191.07 |
| Average True Range (ATR) | 0.02 | 6.99 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 21.43 | 56.28 |
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.